CRSP - CRISPR Therapeutics AG
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$64.60
DETAILS
HIGH:
$82.00
LOW:
$33.00
MEDIAN:
$76.00
CONSENSUS:
$64.60
UPSIDE:
28.28%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue | 3.5 | 35 | 370 | 0.4 | 913.1 | 0.7 | 289.6 | 3.1 | 41.0 | 5.2 | 0.2 | 0 |
| Cost of Revenue | 233.0 | 110.2 | 130.2 | 110.2 | 101.2 | 269.4 | 179.4 | 113.8 | 69.8 | 42.2 | 12.6 | 1.5 |
| Gross Profit | (229.4) | (75.2) | 239.8 | (109.8) | 811.9 | (268.7) | 110.2 | (110.6) | (28.8) | (37.1) | (12.3) | (1.5) |
| Operating Expenses | ||||||||||||
| R&D Expenses | 265.3 | 320.7 | 387.3 | 461.6 | 340.6 | 221.4 | 179.4 | 113.8 | 69.8 | 42.2 | 12.6 | 1.5 |
| SG&A Expenses | 73.5 | 73.0 | 76.2 | 102.5 | 99.7 | 85.7 | 63.5 | 48.3 | 35.8 | 31.1 | 13.4 | 5.1 |
| Other Expenses | 0 | (2.3) | (1.2) | (0.8) | (1.9) | (221.4) | (179.4) | (5.5) | (0.2) | 78.5 | 0.0 | (0.2) |
| Operating Expenses | 338.9 | 391.3 | 462.3 | 563.3 | 438.4 | 85.7 | 63.5 | 162.1 | 105.6 | 73.3 | 26.0 | 6.6 |
| Operating Income | ||||||||||||
| Operating Income | (568.3) | (466.6) | (222.5) | (673.2) | 373.5 | (354.4) | 46.7 | (158.9) | (64.6) | (68.1) | (25.7) | (6.6) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | – | 0 | 0 | 8.1 | 0.1 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | – | 0 | 0 | 0 | 0 | 0 |
| Profitability | ||||||||||||
| EBITDA | (548.8) | (447.3) | (202.7) | (649.0) | 391.5 | (345.3) | 51.5 | (155.4) | (61.6) | (13.7) | (25.6) | (6.6) |
| EBIT | (568.3) | (466.6) | (222.5) | (673.2) | 373.5 | (354.4) | 46.7 | (158.9) | (64.6) | (14.7) | (25.7) | (6.9) |
| Income Before Tax | (578.0) | (362.7) | (150.7) | (650.5) | 379.5 | (348.1) | 67.3 | (164.4) | (66.6) | (22.7) | (25.8) | (6.9) |
| Income Tax Expense | 3.6 | 3.6 | 2.9 | (0.3) | 1.9 | 0.8 | 0.4 | 0.6 | 1.7 | 0.5 | 0.0 | (0.1) |
| Net Income | (581.6) | (366.3) | (153.6) | (650.2) | 377.7 | (348.9) | 66.9 | (165.0) | (68.4) | (23.2) | (25.8) | (6.8) |
| Per Share Data | ||||||||||||
| EPS (Basic) | -6.47 | -4.34 | -1.94 | -8.36 | 4.97 | -5.29 | 1.23 | -3.44 | -1.71 | -1.89 | -0.88 | -0.23 |
| EPS (Diluted) | -6.47 | -4.34 | -1.94 | -8.36 | 4.70 | -5.29 | 1.17 | -3.44 | -1.71 | -1.89 | -0.88 | -0.23 |
| Shares Outstanding | 89.9 | 84.4 | 79.2 | 77.7 | 75.9 | 65.9 | 54.4 | 48.0 | 40.0 | 12.3 | 29.3 | 29.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 355.2 | 298.3 | 389.5 | 211.9 | 923.0 | 1,168.6 | 943.8 | 456.6 | 239.8 | 315.5 |
| Short-Term Investments | 1,628.3 | 1,605.6 | 1,304.2 | 1,603.4 | 1,456.1 | 521.7 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 25 | 200 | 0 | 0.3 | 10.8 | 0.1 | 0.1 | 2.6 | 3.2 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 9.8 | 8.3 | 6.5 | 11.7 | 8.4 | 0 | 0 | 9.7 | 6.0 | 1.5 |
| Total Current Assets | 1,985.7 | 1,937.1 | 1,908.1 | 1,853.0 | 2,417.5 | 1,716.6 | 987.5 | 466.4 | 248.4 | 320.2 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 247.6 | 277.6 | 305.9 | 320.6 | 312.0 | 93.0 | 72.8 | 18.5 | 18.9 | 21.0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 | 0.4 |
| Long-Term Investments | 0 | 0 | 2.0 | 53.1 | 0 | 0 | 5.0 | 3.2 | 3.2 | 3.1 |
| Other Non-Current Assets | 32.0 | 27.3 | 13.6 | 16.3 | 22.2 | 18.1 | 6.1 | 3.8 | 3.8 | 3.3 |
| Total Non-Current Assets | 279.6 | 304.9 | 321.5 | 390.0 | 334.4 | 111.3 | 79.2 | 22.6 | 23.0 | 24.8 |
| Total Assets | 2,265.2 | 2,242.0 | 2,229.6 | 2,243.1 | 2,751.9 | 1,828.0 | 1,066.8 | 489.0 | 271.3 | 345.0 |
| Current Liabilities | ||||||||||
| Account Payables | 11.1 | 14.7 | 38.1 | 27.4 | 14.8 | 9.1 | 5.9 | 5.1 | 1.6 | 4.6 |
| Short-Term Debt | 18.6 | 17.3 | 15.6 | 15.8 | 12.2 | 11.4 | 8.5 | 0 | 0 | 0 |
| Deferred Revenue | 15.8 | 3.8 | 4.1 | 0 | 1.0 | 2.3 | 1.0 | 0 | 0 | 0 |
| Other Current Liabilities | 89.6 | 33.0 | 33.1 | 58.5 | 67.5 | 38.6 | 25.9 | 15.0 | 7.0 | 14.8 |
| Total Current Liabilities | 149.1 | 87.8 | 108.8 | 121.1 | 119.9 | 94.3 | 57.1 | 27.7 | 14.5 | 22.0 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 188.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | (182.0) | 3.4 | 1.0 | 6.0 | 7.3 | 7.6 | 14.4 | 11.3 | 12.1 | 12.5 |
| Total Non-Current Liabilities | 194.3 | 222.2 | 238.0 | 246.5 | 232.5 | 69.5 | 70.2 | 69.1 | 69.0 | 90.1 |
| Total Liabilities | 343.4 | 310.0 | 346.8 | 367.6 | 352.4 | 163.7 | 127.3 | 96.8 | 83.5 | 112.1 |
| Stockholders' Equity | ||||||||||
| Common Stock | 3.1 | 2.7 | 2.5 | 2.4 | 2.4 | 2.3 | 1.8 | 1.6 | 1.2 | 1.2 |
| Retained Earnings | (1,947.6) | (1,366.0) | (999.7) | (846.1) | (195.9) | (573.6) | (224.7) | (291.6) | (125.4) | (57.1) |
| Accumulated Other Comprehensive Income | 4.8 | 1.8 | 1.9 | (15.6) | (5.1) | (0.1) | 0.0 | (0.0) | 0.0 | (0.0) |
| Total Stockholders' Equity | 1,921.8 | 1,932.1 | 1,882.8 | 1,875.5 | 2,399.5 | 1,664.2 | 939.4 | 392.2 | 187.8 | 232.8 |
| Total Liabilities & Equity | 2,265.2 | 2,242.0 | 2,229.6 | 2,243.1 | 2,751.9 | 1,828.0 | 1,066.8 | 489.0 | 271.3 | 345.0 |
| Debt Metrics | ||||||||||
| Total Debt | 394.9 | 223.7 | 238.6 | 244.0 | 225.0 | 61.4 | 52.5 | 0 | 0 | 0 |
| Net Debt | 39.7 | (74.6) | (150.8) | 32.1 | (698.0) | (1,107.2) | (891.2) | (456.6) | (239.8) | (315.5) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (581.6) | (366.3) | (153.6) | (650.2) | 377.7 | (348.9) | 66.9 | (165.0) | (68.4) | (23.2) |
| Depreciation & Amortization | 19.5 | 19.3 | 19.8 | 24.2 | 18.0 | 9.2 | 4.7 | 3.5 | 3.0 | 0.9 |
| Stock-Based Compensation | 72.5 | 86.6 | 81.0 | 97.9 | 102.4 | 66.0 | 44.1 | 35.0 | 18.9 | 10.8 |
| Change in Working Capital | 71.9 | 156.3 | (193.6) | 19.8 | 26.9 | 33.4 | (48.4) | 10.6 | (25.4) | 1.8 |
| Other Non-Cash Items | 72.7 | (38.6) | (14.0) | 12.5 | 14.1 | 1.9 | (10.5) | 15.4 | 1.8 | 8.1 |
| Operating Cash Flow | (345.0) | (142.8) | (260.4) | (495.7) | 539.0 | (238.4) | 56.7 | (96.2) | (70.1) | (55.3) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.9) | (1.9) | (9.5) | (37.2) | (81.7) | (18.4) | (6.7) | (2.8) | (7.8) | (3.0) |
| Acquisitions | 0 | 0 | 0 | 221.5 | 953.7 | 522.8 | 0 | 0 | 0 | (0.1) |
| Purchases of Investments | (1,008.2) | (1,486.4) | (1,065.9) | (1,417.8) | (1,509.3) | (594.0) | 0 | 0 | (0.5) | (0.1) |
| Sales/Maturities of Investments | 1,011.3 | 1,207.8 | 1,452.5 | 1,196.3 | 555.6 | 71.2 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (34.0) | 0 | (2.5) | (221.5) | (953.7) | (522.8) | 8.0 | 0 | (0.5) | 35 |
| Investing Cash Flow | (31.8) | (280.5) | 374.6 | (258.7) | (1,035.4) | (541.2) | 1.3 | (2.8) | (8.3) | 31.9 |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35.0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 31.3 | 0 | 37.6 | 37.7 | 33.9 | 16.0 | 8.9 | 2.6 | (1.8) |
| Financing Cash Flow | 426.0 | 332.0 | 62.7 | 38.6 | 250.9 | 1,016.2 | 431.0 | 315.9 | 2.6 | 183.2 |
| Cash Position | ||||||||||
| Net Change in Cash | 49.3 | (91.3) | 177.6 | (715.9) | (245.5) | 236.7 | 489 | 216.9 | (75.8) | 159.6 |
| Cash at Beginning | 309.8 | 401.1 | 211.9 | 939.9 | 1,185.5 | 948.8 | 459.8 | 242.9 | 315.5 | 156.0 |
| Cash at End | 359.1 | 309.8 | 389.5 | 224.1 | 939.9 | 1,185.5 | 948.8 | 459.8 | 239.8 | 315.5 |
| Free Cash Flow | (345.9) | (144.7) | (269.8) | (532.9) | 457.3 | (256.7) | 50.0 | (99.0) | (77.9) | (58.3) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | 3.5 | 35 | 370 | 0.4 | 913.1 | 0.7 | 289.6 | 3.1 | 41.0 | 5.2 | 0.2 | 0 |
| Gross Profit | (229.4) | (75.2) | 239.8 | (109.8) | 811.9 | (268.7) | 110.2 | (110.6) | (28.8) | (37.1) | (12.3) | (1.5) |
| Operating Income | (568.3) | (466.6) | (222.5) | (673.2) | 373.5 | (354.4) | 46.7 | (158.9) | (64.6) | (68.1) | (25.7) | (6.6) |
| Net Income | (581.6) | (366.3) | (153.6) | (650.2) | 377.7 | (348.9) | 66.9 | (165.0) | (68.4) | (23.2) | (25.8) | (6.8) |
| EPS (Diluted) | -6.47 | -4.34 | -1.94 | -8.36 | 4.70 | -5.29 | 1.17 | -3.44 | -1.71 | -1.89 | -0.88 | -0.23 |
| Balance Sheet | ||||||||||||
| Cash & Equivalents | 355.2 | 298.3 | 389.5 | 211.9 | 923.0 | 1,168.6 | 943.8 | 456.6 | 239.8 | 315.5 | ||
| Total Assets | 2,265.2 | 2,242.0 | 2,229.6 | 2,243.1 | 2,751.9 | 1,828.0 | 1,066.8 | 489.0 | 271.3 | 345.0 | ||
| Total Debt | 394.9 | 223.7 | 238.6 | 244.0 | 225.0 | 61.4 | 52.5 | 0 | 0 | 0 | ||
| Stockholders' Equity | 1,921.8 | 1,932.1 | 1,882.8 | 1,875.5 | 2,399.5 | 1,664.2 | 939.4 | 392.2 | 187.8 | 232.8 | ||
| Cash Flow | ||||||||||||
| Operating Cash Flow | (345.0) | (142.8) | (260.4) | (495.7) | 539.0 | (238.4) | 56.7 | (96.2) | (70.1) | (55.3) | ||
| Capital Expenditure | (0.9) | (1.9) | (9.5) | (37.2) | (81.7) | (18.4) | (6.7) | (2.8) | (7.8) | (3.0) | ||
| Free Cash Flow | (345.9) | (144.7) | (269.8) | (532.9) | 457.3 | (256.7) | 50.0 | (99.0) | (77.9) | (58.3) | ||